로딩 중…
지수 로딩 중…
Sinil Pharmaceutical Co., Ltd.
012790· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩6,280+3.12%
2026-11-02
Financials
Valuation Metrics
Sinil Pharmaceutical Co., Ltd.'s Market Cap is ₩753B. At end of 2025 it was ₩728B. Ranked #1406 of 2,410 in KR market (top 58%), #793 of 1,631 on KOSDAQ (top 49%), #153 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 66%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 75.27B KRW | KR#1,406/2,410 Sec#153/231 |
| Revenue | 86.82B KRW | KR#1,495/2,410 Sec#93/231 |
| Net Income | 6.42B KRW | KR#1,121/2,410 Sec#70/231 |
| Total Assets | 169.49B KRW | KR#1,422/2,410 Sec#107/231 |
| Net Assets | 152.35B KRW | KR#1,122/2,410 Sec#78/231 |
| Employees | 408 | KR#594/2,410 Sec#50/231 |
| Value | ||
| P/E | 11.73x | KR#955/2,410 Sec#52/231 |
| P/B | 0.49x | KR#845/2,410 Sec#36/231 |
| P/S | 0.87x | KR#1,345/2,410 Sec#78/231 |
| EV/EBITDA | 11.30x | KR#713/2,410 Sec#36/231 |
| FCF Yield | 11.29% | KR#593/2,410 Sec#21/231 |
| Profitability | ||
| ROE | 4.21% | KR#1,190/2,410 Sec#84/231 |
| ROA | 3.79% | KR#917/2,410 Sec#76/231 |
| Op. Margin | 6.72% | KR#754/2,410 Sec#62/231 |
| Revenue Growth | 7.22% | KR#1,055/2,410 Sec#101/231 |
| Earnings Growth | -44.06% | KR#1,038/2,410 Sec#67/231 |
| Financial Health | ||
| Debt Ratio | 11.25% | KR#169/2,410 Sec#34/231 |
| Total Debt | 0 KRW | KR—/2,410 Sec—/231 |
| FCF | 8.50B KRW | KR#754/2,410 Sec#41/231 |
| Cash | 9.31B KRW | KR#1,731/2,410 Sec#149/231 |
| Net Debt/EBITDA | -1.60x | KR#279/2,410 Sec#13/231 |
| Dividend | ||
| Div. Yield | 3.02% | KR#663/2,410 Sec#32/231 |
| Div. Growth | 0.00% | KR—/2,410 Sec—/231 |
| Performance | ||
| 1Y Return | 6.80% | KR#492/2,410 Sec#28/231 |
| 1M Return | -3.09% | KR#507/2,410 Sec#55/231 |
| From 52W High | -7.92% | KR#45/2,410 Sec#1/231 |
| 1Y MDD | -24.38% | KR#128/2,410 Sec#9/231 |
| Trading | ||
| Volume | 11,847 shares | KR#1,668/2,410 Sec#172/231 |
| Trading Value | 74.3M KRW | KR#1,493/2,410 Sec#154/231 |
| Foreign Own. | 3.09% | KR#1,257/2,410 Sec#116/231 |
| Per Share | ||
| EPS | 535 KRW | KR#967/2,410 Sec#67/231 |
| BPS | 12,710 KRW | KR#817/2,410 Sec#55/231 |
Company Info
동사는 1971년 설립되어 1999년 코스닥시장에 상장한 중소기업임. 캡슐제, 시럽제, 연고/크림제, 주사제 등 다양한 의약품을 전국 영업망을 통해 의료기관에 공급하며, 다품종 제품 생산 노하우와 우수한 품질관리 시스템을 바탕으로 약 80개 제약사 대상 CDMO사업을 영위하고 있음. 또한 제약기술을 활용한 기능성화장품 및 건강기능식품 통합 브랜드 팜트리를 운영하며 의약외품 사업을 진행하고 있음. 신일제약는 1977년에 설립되었으며 충북 충주시에 본사를 두고 있습니다.